Episode three of four on Paediatric ENT. Doctors Lisa and Sara are back with Paediatric Ear Nose and Throat Consultant Dr Simone Schaefer for this episode on Recurrent Epistaxis in Children. We discuss important differentials, including a rare condition that can present in predominantly teenage boys not to be missed, before moving on to discuss options for management and why the vast majority of these patients can often be safely managed in the community. We discuss cases that would be useful to be seen by the ENT...
Episode three of four on Paediatric ENT. Doctors Lisa and Sara are back with Paediatric Ear Nose and Throat Consultant Dr Simone Schaefer for this episode on Recurrent Epistaxis in Children. We discuss important differentials, including a rare condition that can present in predominantly teenage boys not to be missed, before moving on to discuss options for management and why the vast majority of these patients can often be safely managed in the community. We discuss cases that would be useful to be seen by the ENT team. Short and sweet, full of useful resources.
You can use these podcasts as part of your CPD - we don’t do certificates but they still count :)
Resources:
- Success Rates of Naseptin (Chlorhexidine dihydrochloride and neomycin sulfate) in reducing Epistaxis: Garry S, Wauchope J, Hintze J, Ryan E, O'Cathain E, Heffernan C. Factors affecting Naseptin treatment success – A prospective cohort study. International Journal of Pediatric Otorhinolaryngology. Volume 171. 2023: https://www.sciencedirect.com/science/article/abs/pii/S0165587623001878#:~:text=80.8%25%20(n%20%3D%20101),effects%20(skin%20irritation%20etc.)
- ENT UK: How to use a Nasal Spray: https://www.entuk.org/patients/conditions/79/how_to_use_nasal_sprays/
- Asthma and Lung UK, How to use a Nasal Spray useful Video for patients: https://www.youtube.com/watch?v=S31maomo1xQ
- Alder Hey Children’s Hospital Patient leaflet: Nosebleeds: https://www.alderhey.nhs.uk/conditions/symptoms-checker/nosebleeds/
We really want to make these episodes relevant and helpful: if you have any questions or want any particular areas covered then contact us on Twitter @PCKBpodcast, or leave a comment on our quick anonymous survey here: https://pckb.org/feedback
Email us at: primarycarepodcasts@gmail.com
___
This podcast has been made with the support of GP Excellence and Greater Manchester Integrated Care Board. Given that it is recorded with Greater Manchester clinicians, the information discussed may not be applicable elsewhere and it is important to consult local guidelines before making any treatment decisions.
The information presented is the personal opinion of the healthcare professional interviewed and might not be representative to all clinicians. It is based on their interpretation of current best practice and guidelines when the episode was recorded. Guidelines can change; To the best of our knowledge the information in this episode is up to date as of it’s release but it is the listeners responsibility to review the information and make sure it is still up to date when they listen.
Dr Lisa Adams, Dr Sara MacDermott and their interviewees are not liable for any advice, investigations, course of treatment, diagnosis or any other information, services or products listeners might pursue as a result of listening to this podcast - it is the clinicians responsibility to appraise the information given and review local and national guidelines before making treatment decisions. Reliance on information provided in this podcast is solely at the listeners risk.
The podcast is designed to be used by trained healthcare professionals for education only. We do not recommend these for patients or the general public and they are not to be used as a method of diagnosis, opinion, treatment or medical advice for the general public. Do not delay seeking medical advice based on the information contained in this podcast. If you have questions regarding your health or feel you may have a medical condition then promptly seek the opinion of a trained healthcare professional.
View more
